These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

423 related items for PubMed ID: 15659499

  • 1. Results of induction chemotherapy in children older than 1 year with a stage 4 neuroblastoma treated with the NB 97 French Society of Pediatric Oncology (SFOP) protocol.
    Valteau-Couanet D, Michon J, Boneu A, Rodary C, Perel Y, Bergeron C, Rubie H, Coze C, Plantaz D, Bernard F, Chastagner P, Bouzy J, Hartmann O.
    J Clin Oncol; 2005 Jan 20; 23(3):532-40. PubMed ID: 15659499
    [Abstract] [Full Text] [Related]

  • 2. Reduction from seven to five cycles of intensive induction chemotherapy in children with high-risk neuroblastoma.
    Kushner BH, Kramer K, LaQuaglia MP, Modak S, Yataghene K, Cheung NK.
    J Clin Oncol; 2004 Dec 15; 22(24):4888-92. PubMed ID: 15611504
    [Abstract] [Full Text] [Related]

  • 3. [Evaluation of efficacy of treatment for 30 children with neuroblastoma].
    Sun XF, Liu DG, Su YS, Lin TY, Chen XQ, He YJ.
    Ai Zheng; 2003 Dec 15; 22(12):1343-5. PubMed ID: 14693065
    [Abstract] [Full Text] [Related]

  • 4. Treatment of advanced neuroblastoma: feasibility and therapeutic potential of a novel approach combining 131-I-MIBG and multiple drug chemotherapy.
    Mastrangelo S, Tornesello A, Diociaiuti L, Pession A, Prete A, Rufini V, Troncone L, Mastrangelo R.
    Br J Cancer; 2001 Feb 15; 84(4):460-4. PubMed ID: 11207038
    [Abstract] [Full Text] [Related]

  • 5. Neuroblastoma.
    Meir HM, Balawi I, Nayel H, Yousef MK, Badawood S, Al-Mobarak M.
    Saudi Med J; 2001 Aug 15; 22(8):674-80. PubMed ID: 11573111
    [Abstract] [Full Text] [Related]

  • 6. Phase I study of high-dose continuous intravenous infusion of VP-16 in combination with high-dose melphalan followed by autologous bone marrow transplantation in children with stage IV neuroblastoma.
    Valteau-Couanet D, Vassal G, Pondarré C, Bonnay M, Benhamou E, Couanet D, Plantaz D, Hartmann O.
    Bone Marrow Transplant; 1996 Apr 15; 17(4):485-9. PubMed ID: 8722343
    [Abstract] [Full Text] [Related]

  • 7. Disseminated neuroblastoma in children older than one year at diagnosis: comparable results with three consecutive high-dose protocols adopted by the Italian Co-Operative Group for Neuroblastoma.
    De Bernardi B, Nicolas B, Boni L, Indolfi P, Carli M, Cordero Di Montezemolo L, Donfrancesco A, Pession A, Provenzi M, di Cataldo A, Rizzo A, Tonini GP, Dallorso S, Conte M, Gambini C, Garaventa A, Bonetti F, Zanazzo A, D'Angelo P, Bruzzi P, Italian Co-Operative Group for Neuroblastoma.
    J Clin Oncol; 2003 Apr 15; 21(8):1592-601. PubMed ID: 12697885
    [Abstract] [Full Text] [Related]

  • 8. Treatment of advanced neuroblastoma in children over 1 year of age: the critical role of ¹³¹I-metaiodobenzylguanidine combined with chemotherapy in a rapid induction regimen.
    Mastrangelo S, Rufini V, Ruggiero A, Di Giannatale A, Riccardi R.
    Pediatr Blood Cancer; 2011 Jul 01; 56(7):1032-40. PubMed ID: 21344615
    [Abstract] [Full Text] [Related]

  • 9. NB87 induction protocol for stage 4 neuroblastoma in children over 1 year of age: a report from the French Society of Pediatric Oncology.
    Coze C, Hartmann O, Michon J, Frappaz D, Dusol F, Rubie H, Plouvier E, Leverger G, Bordigoni P, Béhar C, Beck D, Mechinaud F, Bergeron C, Plantaz D, Otten J, Zucker JM, Philip T, Bernard JL.
    J Clin Oncol; 1997 Dec 01; 15(12):3433-40. PubMed ID: 9396394
    [Abstract] [Full Text] [Related]

  • 10. Peripheral blood stem cell support reduces the toxicity of intensive chemotherapy for children and adolescents with metastatic sarcomas.
    Hawkins DS, Felgenhauer J, Park J, Kreissman S, Thomson B, Douglas J, Rowley SD, Gooley T, Sanders JE, Pendergrass TW.
    Cancer; 2002 Sep 15; 95(6):1354-65. PubMed ID: 12216105
    [Abstract] [Full Text] [Related]

  • 11. N7: a novel multi-modality therapy of high risk neuroblastoma (NB) in children diagnosed over 1 year of age.
    Cheung NK, Kushner BH, LaQuaglia M, Kramer K, Gollamudi S, Heller G, Gerald W, Yeh S, Finn R, Larson SM, Wuest D, Byrnes M, Dantis E, Mora J, Cheung IY, Rosenfield N, Abramson S, O'Reilly RJ.
    Med Pediatr Oncol; 2001 Jan 15; 36(1):227-30. PubMed ID: 11464891
    [Abstract] [Full Text] [Related]

  • 12. [Curative effects of the protocol of CDV combined with CiE as pre-operative chemotherapy in high-risk childhood neuroblastoma].
    Feng C, Tang SQ, Wang JW, Liu Y, Yang G.
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Nov 15; 11(11):885-7. PubMed ID: 20113653
    [Abstract] [Full Text] [Related]

  • 13. Granulocyte-colony stimulating factor and multiple cycles of strongly myelosuppressive alkylator-based combination chemotherapy in children with neuroblastoma.
    Kushner BH, Heller G, Kramer K, Cheung NK.
    Cancer; 2000 Nov 15; 89(10):2122-30. PubMed ID: 11066054
    [Abstract] [Full Text] [Related]

  • 14. Poor survival for infants with MYCN-amplified metastatic neuroblastoma despite intensified treatment: the International Society of Paediatric Oncology European Neuroblastoma Experience.
    Canete A, Gerrard M, Rubie H, Castel V, Di Cataldo A, Munzer C, Ladenstein R, Brichard B, Bermúdez JD, Couturier J, de Bernardi B, Pearson AJ, Michon J.
    J Clin Oncol; 2009 Mar 01; 27(7):1014-9. PubMed ID: 19171715
    [Abstract] [Full Text] [Related]

  • 15. A phase II study of topotecan with vincristine and doxorubicin in children with recurrent/refractory neuroblastoma.
    Garaventa A, Luksch R, Biasotti S, Severi G, Pizzitola MR, Viscardi E, Prete A, Mastrangelo S, Podda M, Haupt R, De Bernardi B.
    Cancer; 2003 Dec 01; 98(11):2488-94. PubMed ID: 14635085
    [Abstract] [Full Text] [Related]

  • 16. Experience of the Izmir Pediatric Oncology Group on Neuroblastoma: IPOG-NBL-92 Protocol.
    Olgun N, Kansoy S, Aksoylar S, Cetingul N, Vergin C, Oniz H, Sarialioglu F, Kantar M, Uysal K, Tuncyurek M, Kargi A, Aktas S, Bayol U, Karaca I, Arikan A, Balik E, Aktug T, Elmas N, Kovanlikaya A, Kinay M, Anacak Y, Degirmenci B, Burak Z.
    Pediatr Hematol Oncol; 2003 Dec 01; 20(3):211-8. PubMed ID: 12637217
    [Abstract] [Full Text] [Related]

  • 17. A phase II trial of combination chemotherapy and surgical resection for the treatment of metastatic adrenocortical carcinoma: continuous infusion doxorubicin, vincristine, and etoposide with daily mitotane as a P-glycoprotein antagonist.
    Abraham J, Bakke S, Rutt A, Meadows B, Merino M, Alexander R, Schrump D, Bartlett D, Choyke P, Robey R, Hung E, Steinberg SM, Bates S, Fojo T.
    Cancer; 2002 May 01; 94(9):2333-43. PubMed ID: 12015757
    [Abstract] [Full Text] [Related]

  • 18. Impact of metaiodobenzylguanidine scintigraphy on assessing response of high-risk neuroblastoma to dose-intensive induction chemotherapy.
    Kushner BH, Yeh SD, Kramer K, Larson SM, Cheung NK.
    J Clin Oncol; 2003 Mar 15; 21(6):1082-6. PubMed ID: 12637474
    [Abstract] [Full Text] [Related]

  • 19. The treatment of neuroblastoma with [131I]MIBG at diagnosis.
    Troncone L, Rufini V, Luzi S, Mastrangelo R, Riccardi R.
    Q J Nucl Med; 1995 Dec 15; 39(4 Suppl 1):65-8. PubMed ID: 9002753
    [Abstract] [Full Text] [Related]

  • 20. Increasing chemotherapy dose density and intensity: phase I trials in non-small cell lung cancer and non-Hodgkin's lymphoma.
    Blayney DW, McGuire BW, Cruickshank SE, Johnson DH.
    Oncologist; 2005 Feb 15; 10(2):138-49. PubMed ID: 15709216
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.